Skip to main content

Advertisement

SpringerLink
Log in

Targeting the Central Histamine H2 Receptor: New Hope for Schizophrenia?

  • Research Highlight
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hu W, Chen Z. The roles of histamine and its receptor ligands in central nervous system disorders: An update. Pharmacol Ther 2017, 175: 116–132.

    Article  CAS  PubMed  Google Scholar 

  2. Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev 2015, 67: 601–655.

    Article  CAS  PubMed Central  Google Scholar 

  3. Cheng L, Xu C, Wang L, An D, Jiang L, Zheng Y. Histamine H1 receptor deletion in cholinergic neurons induces sensorimotor gating ability deficit and social impairments in mice. Nat Commun 2021, 12: 1142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Panula P, Nuutinen S. The histaminergic network in the brain: Basic organization and role in disease. Nat Rev Neurosci 2013, 14: 472–487.

    Article  CAS  PubMed  Google Scholar 

  5. Kaminsky R, Moriarty TM, Bodine J, Wolf DE, Davidson M. Effect of famotidine on deficit symptoms of schizophrenia. Lancet 1990, 335: 1351–1352.

    Article  CAS  PubMed  Google Scholar 

  6. Rosse RB, Kendrick K, Fay-McCarthy M, Prell GD, Rosenberg P, Tsui LC, et al. An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: Preliminary evidence for treatment efficacy. Clin Neuropharmacol 1996, 19: 341–348.

    Article  CAS  PubMed  Google Scholar 

  7. Ma Q, Jiang L, Chen H, An D, Ping Y, Wang Y, et al. Histamine H2 receptor deficit in glutamatergic neurons contributes to the pathogenesis of schizophrenia. Proc Natl Acad Sci U S A 2023, 120: e2207003120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Carter CJ. Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 2006, 86: 1–14.

    Article  CAS  PubMed  Google Scholar 

  9. Eriks JC, van der Goot H, Sterk GJ, Timmerman H. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles. J Med Chem 1992, 35: 3239–3246.

  10. Andrade C. Famotidine augmentation in schizophrenia: Hope or hype? J Clin Psychiatry 2013, 74: e855–e858.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, 310053, China

    Wenkai Lin, Xuemin Yu & Xinyan Zhu

Authors
  1. Wenkai Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xuemin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinyan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wenkai Lin.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, W., Yu, X. & Zhu, X. Targeting the Central Histamine H2 Receptor: New Hope for Schizophrenia?. Neurosci. Bull. 40, 143–145 (2024). https://doi.org/10.1007/s12264-023-01122-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-023-01122-w

Search

Navigation